USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: ITI HEALTH, INC.
Address: 1076 AUTUMN HILL CT
CROZET, VA 22932-3140
Located in HUBZone: No
Woman-Owned: Yes
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $850,670.00 3

Award List:

Developing a plectin-1 targeted imaging agent for the detection of pancreatic can

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Greg B. Fralish – 434-298-4844
Award Amount: $299,999.00
Abstract:
DESCRIPTION (provided by applicant): Pancreatic ductal adenocarcinoma (PDAC) is an intractable clinical problem, typically presenting with metastasis at the time of diagnosis and exhibiting profound resistance to existing therapies. Currently, the standarddiagnostic course includes CT or MRI scans… More

TAS::75 0849::TAS SBIR TOPIC 307 PHASE I NOVEL IMAGING AGENTS TO EXPAND THE CLINICAL TOOLKIT FOR CANCER DIAGNOSIS, STAGING, AND TREATMENT

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Greg Fralish – 434-298-4844
Award Amount: $249,330.00
Abstract:
Phase I - Topic 307 The long term objective of this work is to transform the clinical practice of diagnosing and treating pancreatic cancer through the development of a targeted imaging reagent. The 5-year survival rate for patients diagnosed with pancreatic cancer is less than 5%. Those with… More

Development of a plectin-1 targeted payload delivery system for treating pancreat

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Greg B. Fralish – 434-298-4844
Award Amount: $301,341.00
Abstract:
DESCRIPTION (provided by applicant): While only the 31st most common cause of cancer, pancreatic cancer is the fourth most common cause of cancer-related death in the US. Patients typically present with advanced disease that is notoriously refractory to chemotherapy. Indeed, the 5 year survival rate… More